Cita APA

Hifumi, T., Isokawa, S., Otani, N., & Ishimatsu, S. (2020). Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients. Crit Care.

Citación estilo Chicago

Hifumi, Toru, Shutaro Isokawa, Norio Otani, y Shinichi Ishimatsu. "Adverse Events Associated With Nafamostat Mesylate and Favipiravir Treatment in COVID-19 Patients." Crit Care 2020.

Cita MLA

Hifumi, Toru, Shutaro Isokawa, Norio Otani, y Shinichi Ishimatsu. "Adverse Events Associated With Nafamostat Mesylate and Favipiravir Treatment in COVID-19 Patients." Crit Care 2020.